Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology R Palmirotta, D Lovero, P Cafforio, C Felici, F Mannavola, E Pellè, ... Therapeutic advances in medical oncology 10, 1758835918794630, 2018 | 424 | 2018 |
Immune system and melanoma biology: a balance between immunosurveillance and immune escape A Passarelli, F Mannavola, LS Stucci, M Tucci, F Silvestris Oncotarget 8 (62), 106132, 2017 | 230 | 2017 |
Non-melanoma skin cancers: Biological and clinical features M Cives, F Mannavola, L Lospalluti, MC Sergi, G Cazzato, E Filoni, ... International Journal of Molecular Sciences 21 (15), 5394, 2020 | 136 | 2020 |
Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity M Tucci, F Mannavola, A Passarelli, LS Stucci, M Cives, F Silvestris Oncotarget 9 (29), 20826, 2018 | 114 | 2018 |
Immune system evasion as hallmark of melanoma progression: the role of dendritic cells M Tucci, A Passarelli, F Mannavola, C Felici, LS Stucci, M Cives, ... Frontiers in oncology 9, 1148, 2019 | 113 | 2019 |
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma M Tucci, A Passarelli, F Mannavola, LS Stucci, PA Ascierto, M Capone, ... Oncoimmunology 7 (2), e1387706, 2018 | 87 | 2018 |
The ATM gene in breast cancer: Its relevance in clinical practice LS Stucci, V Internò, M Tucci, M Perrone, F Mannavola, R Palmirotta, ... Genes 12 (5), 727, 2021 | 47 | 2021 |
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis F Mannavola, M Tucci, C Felici, A Passarelli, S D’Oronzo, F Silvestris Journal of translational medicine 17, 1-15, 2019 | 47 | 2019 |
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? F Mannavola, T Salerno, A Passarelli, M Tucci, V Internò, F Silvestris Frontiers in Oncology 9, 521, 2019 | 43 | 2019 |
Extracellular vesicles and epigenetic modifications are hallmarks of melanoma progression F Mannavola, S D’Oronzo, M Cives, LS Stucci, G Ranieri, F Silvestris, ... International Journal of Molecular Sciences 21 (1), 52, 2019 | 42 | 2019 |
miRNAs in melanoma: a defined role in tumor progression and metastasis F Mannavola, M Tucci, C Felici, S Stucci, F Silvestris Expert Review of Clinical Immunology 12 (1), 79-89, 2016 | 40 | 2016 |
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine A Passarelli, M Tucci, F Mannavola, C Felici, F Silvestris Tumor Biology 41 (4), 1010428319837138, 2019 | 38 | 2019 |
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients B Vincenzi, C Cremolini, A Sartore-Bianchi, A Russo, F Mannavola, ... Oncotarget 6 (31), 31604, 2015 | 37 | 2015 |
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma M Tucci, A Passarelli, A Todisco, F Mannavola, LS Stucci, S D’Oronzo, ... Therapeutic Advances in Medical Oncology 11, 1758835919875549, 2019 | 31 | 2019 |
pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo P Cafforio, L Viggiano, F Mannavola, E Pellè, C Caporusso, E Maiorano, ... Stem cell research & therapy 8, 1-13, 2017 | 30 | 2017 |
A lipidomic approach to identify potential biomarkers in exosomes from melanoma cells with different metastatic potential S Lobasso, P Tanzarella, F Mannavola, M Tucci, F Silvestris, C Felici, ... Frontiers in physiology 12, 748895, 2021 | 24 | 2021 |
Large Extracellular Vesicles—A New Frontier of Liquid Biopsy in Oncology G Pezzicoli, M Tucci, D Lovero, F Silvestris, C Porta, F Mannavola International Journal of Molecular Sciences 21 (18), 6543, 2020 | 21 | 2020 |
Randomized intermittent or continuous panitumumab plus FOLFIRI (FOLFIRI/PANI) for first-line treatment of patients (pts) with RAS/BRAF wild-type (wt) metastatic colorectal … A Avallone, F Giuliani, G Nasti, V Montesarchio, G Santabarbara, S Leo, ... Journal of Clinical Oncology 40 (16_suppl), 3503-3503, 2022 | 16 | 2022 |
Melanoma and immunotherapy bridge 2015: Naples, Italy. 1–5 December 2015 VGY Nanda, W Peng, P Hwu, MA Davies, G Ciliberto, L Fattore, ... Journal of Translational Medicine 14, 1-27, 2016 | 15 | 2016 |
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors B Mandriani, E Pellè, F Mannavola, A Palazzo, RM Marsano, G Ingravallo, ... Journal for Immunotherapy of Cancer 10 (6), 2022 | 14 | 2022 |